Novel antibacterial hydroxyphenyl compound

Details for Australian Patent Application No. 2009352134 (hide)

Owner FAB Pharma SAS

Inventors Gerusz, Vincent; Faivre, Fabien; Oxoby, Mayalen; Denis, Alexis; Bonvin, Yannick

Agent Davies Collison Cave

Pub. Number AU-A-2009352134

PCT Pub. Number WO2011/026529

Priority 61/238,995 01.09.09 US

Filing date 11 November 2009

Wipo publication date 10 March 2011

International Classifications

C07C 235/44 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07C 255/54 (2006.01) Carboxylic acid nitriles

Event Publications

1 March 2012 PCT application entered the National Phase

  PCT publication WO2011/026529 Priority application(s): WO2011/026529

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009352159-Packed bed bioreactor for biofouling control of reverse osmosis and nano- filtration membranes

2009352124-Method for characterizing the combustion in lines of partitions of a furnace having rotary firing chamber(s)